CLOSTRIDIUM DIFFICILE TOXIN A ENZYME IMMUNOASSAY— 510(k) K904329

Substantially Equivalent

Baxter Healthcare Corp

FDA 510(k) clearance K904329 for CLOSTRIDIUM DIFFICILE TOXIN A ENZYME IMMUNOASSAY, Substantially Equivalent on 1991-03-12. Applicant: Baxter Healthcare Corp.

Clearance details

Applicant: Baxter Healthcare Corp
Product code: Code MCB
Advisory panel: Microbiology
Date received: 1990-09-20
Decision date: 1991-03-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bellevue, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.